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Abstract
Background: Acute intoxication with organophosphorus (OP) cholinesterase inhibitors can trigger convulsions that
progress to life-threatening status epilepticus. Survivors face long-term morbidity including mild-to-severe decline in
memory. It is posited that neuroinflammation plays a key role in the pathogenesis of OP-induced neuropsychiatric
deficits. Rigorous testing of this hypothesis requires preclinical models that recapitulate relevant phenotypic
outcomes. Here, we describe a rat model of acute intoxication with the OP diisopropylfluorophosphate (DFP) that
exhibits persistent neuroinflammation and cognitive impairment.
Methods: Neuroinflammation, neurodegeneration, and cognitive function were compared in adult male Sprague
Dawley rats injected with an acutely toxic dose of DFP vs. vehicle controls at multiple time points up to 36 days
post-exposure. Neuroinflammation was quantified using immunohistochemical biomarkers of microglia (ionized
calcium-binding adapter molecule 1, IBA1) and activated astrocytes (glial fibrillary acidic protein, GFAP) and positron
emission tomography (PET) imaging of [11C]-(R)-PK11195, a ligand for the 18-kDa mitochondrial membrane translocator
protein (TSPO). FluoroJade-B staining was used to assess neurodegeneration; Pavlovian conditioning, to assess
cognitive function.
Results: Animals exhibited moderate-to-severe seizures within minutes of DFP injection that continued for up to
6 h post-injection. As indicated by IBA1 and GFAP immunoreactivity and by PET imaging of TSPO, acute DFP
intoxication triggered neuroinflammation in the hippocampus and cortex during the first 3 days that peaked at
7 days and persisted to 21 days post-exposure in most animals. Neurodegeneration was detected in multiple
brain regions from 1 to 14 days post-exposure. All DFP-intoxicated animals exhibited significant deficits in
contextual fear conditioning at 9 and 20 days post-exposure compared to vehicle controls. Whole-brain TSPO
labeling positively correlated with seizure severity score, but did not correlate with performance in the contextual
fear-conditioning task.
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Conclusions: We describe a preclinical model in which acute DFP intoxication causes seizures, persistent
neuroinflammation, neurodegeneration, and memory impairment. The extent of the neuroinflammatory response
is influenced by seizure severity. However, the observation that a subset of animals with moderate seizures and
minimal TSPO labeling exhibited cognitive deficits comparable to those of animals with severe seizures and
significant TSPO labeling suggests that DFP may impair learning and memory circuitry via mechanisms
independent of seizures or neuroinflammation.
Keywords: Cognitive deficits, Diisopropylfluorophosphate, Neurodegeneration, Neuroinflammation,
Organophosphate neurotoxicity, PET imaging, Sublethal effects, TSPO
Background
Organophosphorus (OP) nerve agents and pesticides that
inhibit acetylcholinesterase represent a major public
health concern [1–3]. Acute intoxication with these OPs
can trigger convulsions that progress to life-threatening
status epilepticus (SE), and survivors face long-term mor-
bidity, including mild-to-severe cognitive deficits, affective
disorders, and recurrent seizures [2–6]. Each year, an esti-
mated 300,000 people die, and many more experience sig-
nificant morbidity, as a result of suicidal and accidental
exposures to OP pesticides [1, 6–8], and there are growing
concerns of civilian mass causalities resulting from terror-
ist use of OP nerve agents or OP pesticides [2, 3, 9, 10].
Current medical countermeasures for OP-induced SE (at-
ropine, oxime, and high-dose benzodiazepine) can termin-
ate seizures and reduce mortality; however, they do so
with significant side effects and are effective in protecting
against long-term morbidity only if administered within
minutes of exposure [2, 5, 7, 8, 11]. These sobering facts
underscore the need for improved therapeutic approaches
to mitigate the long-term neurological sequelae of acute
OP intoxication.
The search for more effective therapeutic strategies has
been complicated by uncertainty regarding the pathogenic
mechanisms linking acute OP intoxication to persistent
neurological deficits. One postulated mechanism is neuro-
inflammation [4, 12, 13]. Much of the evidence in support
of this hypothesis derives from experimental studies of OP
nerve agents (reviewed in [4, 12]; see also [14, 15]). Follow-
ing OP nerve agent-induced SE, there is a rapid and
sustained neuroinflammatory response marked by activa-
tion of microglia and astrocytes [16–18] and significantly
increased brain levels of proinflammatory mediators,
including arachidonic acid metabolites [18, 19] and cyto-
kines [20–25]. These neuroinflammatory responses typic-
ally coincide with neurodegeneration and either precede or
overlap with significant behavioral deficits and recurrent
seizures (reviewed in [3–5, 12, 13]). However, whether neu-
roinflammation is causally linked to long-term neurological
deficits has yet to be established in these models.
It is also unknown whether preclinical models of acute
intoxication with OP nerve agents are predictive of effects
following acute intoxication with OP pesticides. Although
all seizure-inducing OPs are potent cholinesterase inhibi-
tors, each elicits a unique profile of toxic effects [26–28],
inflammatory responses vary between OP nerve agents
and OP pesticides [29–31], and current therapeutic strat-
egies are not equally effective against different OPs [7, 28].
Recent research efforts to address this question have fo-
cused on diisopropylfluorophosphate (DFP), an OP pesti-
cide considered to be a credible chemical threat agent
(Jessica Cox, Department of Homeland Security, personal
communication). Using a rat model of acute DFP intoxica-
tion that induces robust seizure behavior, we recently
reported significant activation of microglia and astrocytes
and upregulation of proinflammatory genes in multiple
brain regions at 24 h post-exposure [32], which are still
evident at 48 to 96 h post-exposure [31, 33, 34]. These
and studies from other groups [35–37] have also docu-
mented neurodegeneration over this same post-exposure
time frame following acute DFP intoxication. Behavioral
studies of acute intoxication with DFP report spatial
learning deficits at 4 weeks post-exposure in the Morris
water maze [38], impairments at 6 to 12 weeks post-
exposure in the novel object recognition task [39], and
higher scores on depression-relevant immobility behav-
ior at 8 and 29 days post-exposure [40]. However, to
date, there are no data documenting long-term effects
on neuroinflammation and functional outcomes in the
same animals following acute intoxication with DFP or
any other seizure-inducing OP pesticide. These data are
critical for assessing the biological plausibility of a causal
link between neuroinflammation and persistent neuro-
logical deficits and for informing mechanistic studies to
rigorously test this hypothesis.
The major goal of this study was to address this data
gap by characterizing long-term effects of acute DFP-
induced SE on neuroinflammation and behavior. The
behavioral readout we chose for these studies was
learning and memory, because deficits in this domain
have been documented in humans who survive acute
OP intoxication [3, 5] and in experimental models of
acute intoxication by DFP [38, 39] and other seizure-
inducing OPs [4]. Neuroinflammation was quantified in
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the hippocampus and frontal cortex because learning and
memory are heavily dependent on the function of these
brain regions [41], and both the hippocampus and cortex
are known to be adversely affected by OP nerve agents
[42]. In addition, we evaluated positron emission tomog-
raphy (PET) imaging of the 18-kDa mitochondrial translo-
cator protein (TSPO) as a non-invasive approach for
longitudinal quantification of neuroinflammation. TSPO
is typically expressed at low levels on the outer mitochon-
drial membrane of glial cells in the brain; however, upon
activation, TSPO expression is significantly upregulated,
making it a useful biomarker of activated microglia and
astrocytes [43, 44]. Using these approaches, we were able
to demonstrate persistent neuroinflammation and im-
paired cognition in animals acutely intoxicated with DFP.
Methods
Animals and DFP exposure
Animals were maintained in facilities fully accredited by
the Association for Assessment and Accreditation of
Laboratory Animal Care, and all studies were performed
with regard for alleviation of pain and suffering under
protocols approved by the UC Davis Institutional Ani-
mal Care and Use Committee. Adult male Sprague
Dawley rats (250–280 g; Charles River Laboratories,
Hollister, CA) were housed individually in standard
plastic cages under controlled environmental conditions
(22 ± 2 °C, 40–50 % humidity) with a normal 12-h light/
dark cycle. Food and water were provided ad libitum. All
animals were allowed to acclimate for 7 days prior to the
initiation of experiments.
Subject rats were injected intraperitoneally (ip) with
DFP (Sigma Chemical Company, St Louis, MO) at
9 mg/kg in a total injection volume of 300 μl. In all stud-
ies, DFP was diluted with sterile saline within 5 min of
administration. To increase survival following DFP ex-
posure, animals were injected intramuscularly (im) with
0.1 mg/kg pyridostigmine bromide (TCI America, Port-
land, OR) in saline and 20 mg/kg atropine methyl nitrate
(TCI America) in saline, 30 and 10 min prior to DFP in-
jection, respectively (Fig. 1). These drugs are centrally
inactive [45] but effectively block peripheral cholinergic
toxicity, thereby reducing mortality [35]. Vehicle con-
trol subjects (VEH) were injected ip with 300 μl saline
in place of DFP but were similarly pretreated with pyri-
dostigmine (0.1 mg/kg, im) and atropine (20 mg/kg,
im). Seizure behavior was monitored for 6 h following
DFP injection using a modified Racine scale (Fig. 1), as
previously described [46]. Once returned to their home
cages, rats were provided DietGel Recovery (ClearH2O,
Portland, ME) for 3–5 days or until they resumed con-
sumption of solid chow.
Histological analyses
For histological analyses, a total of 9 VEH and 23 DFP rats
were dosed; 2–3 VEH animals were euthanized at 1, 3, 7,
and 21 day post-injection; 3–7 DFP animals were eutha-
nized at 1, 2, 3, 7, 14, and 21 days post-injection. Brains
were harvested from animals deeply anesthetized with 5 %
isoflurane in oxygen and subsequently perfused transcar-
dially with cold PBS followed by cold 4 % paraformalde-
hyde solution in phosphate-buffered saline (PBS; pH 7.2).
The brains were post-fixed with 4 % paraformaldehyde at
4 °C for 24 h and then transferred to 30 % sucrose solu-
tion in PBS. Upon removal from the 30 % sucrose solu-
tion, the brains were laterally bisected, frozen in O.C.T.
compound (Sakura Finetek, Torrance, CA) on dry ice, and
then sectioned on a cryostat (Microm HM 505E, Thermo
Fisher, Waltham, MA) to generate 10-μm sagittal sections.
Sections were stored at –80 °C until further processed.
To detect neuronal cell damage, sections were labeled
with FluoroJade-B (FJB) solution (Chemicon Inter-
national, Temecula, CA), as previously described [35].
To assess astrogliosis and microglial cell activation, sec-
tions were immunostained for glial fibrillary acidic pro-
tein (GFAP, 1:500 dilution; Dako, Glostrup, Denmark)
or ionized calcium-binding adapter molecule 1 (IBA1,
1:1000 dilution; Wako Chemicals, Richmond, VA),
Fig. 1 Schematic representation of the rat model of acute DFP intoxication. Adult male Sprague Dawley rats are administered pyridostigmine
bromide and atropine methyl nitrate prior to administration of DFP to increase survival. Parasympathomimetic symptoms (SLUD) appear within
minutes after injection of DFP and rapidly progress to seizures, with status epilepticus beginning within 10 min after DFP exposure. Seizure
behavior is monitored for 6 h post-injection and seizure severity scored from 1 (least severe) to 6 (most severe) as indicated in the figure. SLUD
salivation, lacrimation, urination, and defecation
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respectively, as previously described [47]. GFAP and IBA1
immunoreactivity was visualized by confocal microscopy
and quantified using image analysis software (MetaMorph,
Molecular Devices, Sunnyvale, CA), as previously de-
scribed [47]. Individuals blinded to the treatment condi-
tion determined the number of activated vs. resting IBA1
immunopositive microglia according to published mor-
phologic criteria [48]. Activated and resting microglia
were quantified across the entire hippocampus and along
the entire dorsal boundary of the cortex to an inward
depth of 500 μm from the dorsal edge. All endpoints were
examined in at least three serial sections per animal, and
data were collected from the same level of the brain across
all animals.
In vivo imaging
The radiosynthesis of the TSPO ligand [11C]-(R)-PK11195
was adapted from a previously published method [49].
Briefly, cyclotron (Siemens RDS 111)-produced [11C]CO2
was converted to [11C]CH3I in the gas phase (GE Tracer-
lab FX-C Pro) and bubbled into a solution of (R)-N-des-
methyl-PK11195 (1 mg) and NaH (1–2 mg) in DMSO
(250 μl). The reaction was quenched in H2O (1.5 ml) and
the labeled product purified by semi-preparative high-
performance liquid chromatography on a C-18 column
eluted in 70 % ethanol (aq). The pure product was col-
lected in a vial containing Tween-80 (Sigma) and then
dried (110 °C) before formulation with PBS. Tween-80
(final concentration, 0.6 % v/v) was used to prevent
adsorption of [11C]-(R)-PK11195 onto plastic vials, syrin-
ges, and extension tubing. Twenty-four syntheses were
performed with a decay-corrected yield of 12.7 ± 2.7 %
(mean ± SD) and radiochemical purity of >95 %. The
mean specific activity at the end of the formulation was
2160 ± 1370 Ci/mmol.
Rats (n = 3 VEH and 6 DFP) were imaged using PET
prior to DFP injection to collect baseline TSPO labeling
and then imaged again at 2, 7, and 21 days post-DFP
intoxication. Animals were anesthetized with approxi-
mately 2 % isoflurane in oxygen gas and maintained on
1–2 % isoflurane. Approximately 1.0 mCi of [11C]-(R)-
PK11195 ligand was injected via a tail vein catheter.
Animals were then transferred to the animal bed for
scanning. Two animals were secured onto an imaging
bed in a cheek-to-cheek position, with the middle of the
brains centered in the axial field of view. Twenty-minute
emission scans began 10 min post-injection of [11C]-(R)-
PK11195. Images were acquired with a Focus 120 Small
Animal PET Scanner (Siemens Preclinical Solutions,
Knoxville, TN) with a resolution of 1.3 mm. Animals
were kept warm with heating lamps throughout the im-
aging session.
A single magnetic resonance imaging (MRI) scan was
performed 7–14 days post-DFP intoxication at either the
UC Davis Nuclear Magnetic Resonance (NMR) facility
on a Bruker Biospec 7 tesla scanner operating Paravision
v 4.0 software or at the UC Davis Center for Molecular
and Genomic Imaging on a Bruker Biospec 7 tesla mag-
net operating Paravision v 5.1. Rodent brain imaging was
optimized at the NMR facility using a T2-weighted fast
spin echo (FSE) sequence with TE = 30 ms, TR =
3350 ms, 0.2 mm in-plane resolution (256 × 256 matrix)
zero filled once, and 0.7-mm slice thickness. FSE scans at
the CMGI facility were acquired with TE = 28 ms, TR =
4250 ms, 0.137 mm in-plane resolution (256 × 256 matrix,
zero filled once), and 0.5-mm slice thickness. Scan times
on both systems were approximately 36 min.
Images were analyzed using Inveon Research Workplace
(Siemens Preclinical Solutions) software. Both the PET
and MR images were imported and co-registered for ana-
lysis. Regions of interest for analysis were annotated on
the MR image and included the whole brain, rostral and
caudal hippocampus, amygdala, lateral dorsal thalamus,
medial dorsal thalamus, piriform cortex, somatosensory
cortex, septum, and reuniens nucleus.
Behavioral testing
Learning and memory were assessed using contextual
fear conditioning as previously described [41]. Animals
were trained for conditioned stimulus (CS)-uncondi-
tioned stimulus (UCS) associations using two identical
operant chambers (Med Associates, St. Albans, VT) that
were calibrated to deliver foot shocks at 0.5 or 0.7 mA.
Each chamber was 30.5 cm × 24.1 cm × 21 cm, the side
walls were aluminum, the front wall was clear polycar-
bonate, the back wall and ceiling were opaque Plexiglas,
and the floor was composed of stainless steel rods placed
1.6 cm apart. A scrambled foot shock was delivered
through the floor. Each conditioning chamber was sur-
rounded by a sound-attenuating environmental chamber
and equipped with an overhead CCTV to record behav-
ior. Chambers were thoroughly cleaned with 70 % etha-
nol between subjects.
To condition animals, subjects were placed in a house-
lit chamber for 2 min, followed by presentation of an
auditory CS, 78-dB white noise for 30 s, followed by the
UCS, a 2-s foot shock delivered through the floor grid.
Two separate cohorts of animals were tested. One co-
hort (n = 6 VEH and 6 DFP) received three consecutive
foot shocks at 0.7 mA each with 30 s of silence between
the foot shocks; the second cohort (n = 10 VEH and 16
DFP) received a single foot shock at 0.5 mA. An olfac-
tory cue was added before fear conditioning by dabbing
a drop of lemon dish soap solution on the metal tray be-
neath the grid floor. After the CS-US pairing, subjects
were left in the chamber for another 1 min, during
which time behavior was recorded by a CCTV. Subjects
were then returned to their home cage for 24 h. The
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next day, memory of the fear-associated context was
quantified by placing subjects in the same operant
chamber with identical visual, floor-texture, and olfac-
tory cues as the day before during tone-shock pairing.
Each animal was placed in the chamber for 5 min, and
its behavior recorded in the absence of the auditory CS
and the US foot shock. The rat was then returned to its
home cage. The dependent variable for assessing fear
conditioning was freezing, defined as the absence of any
movement except that needed for respiration. Freezing
was manually scored from videos at 8-s intervals by two
independent observers blinded to treatment.
The open-field test was used to assess locomotion in a
novel open arena in a separate cohort of animals. Sub-
jects (n = 5 per group) were placed in a black matte box
made of medium-density fiberboard (MDF) measuring
50 cm × 50 cm × 45 cm under 65-lx lighting and in 73 °F
room temperature. The total distance traveled by each
subject was tracked for 15 min using center point track-
ing (Ethovision XT9 system, Noldus Information Tech-
nology, Leesburg, VA). Detection settings were set to
static subtraction with video sampling at 10 frames per
second. Upon completion of the task, subjects were
returned to their home cages and the open-field appar-
atus cleaned with 70 % ethanol before the next subject.
Ethovision software was used to calculate the total dis-
tance traveled during the 15-min testing session.
Statistics
The units of statistical analysis for each outcome were
clustered, with observations from each animal being
taken at multiple regions of the brain, at multiple days,
or both. Hence, we used statistical analysis methods for
clustered data to increase the efficiency and robustness
of our analysis by accounting for within-cluster correla-
tions. Statistical analysis began with graphical representa-
tion of study data to identify patterns of central tendency
and variation and to suggest data transformations and
model specifications that would improve the validity of
statistical inferences.
Comparisons among treatment conditions in mean
levels of study outcomes were estimated and tested
using generalized linear models for clustered data in
Version 12 of Stata (College Station, TX), using appro-
priate link and variance functions according to the
distribution of the outcome. Behavioral data were
expressed as proportion time freezing. These were ana-
lyzed using logistic regression techniques for clustered
survey data. Logarithmic transformations were applied
to select count and area measurements to stabilize the
variances for purposes of comparing and to allow the
use of mixed-effects linear regression techniques on the
log-transformed data. Otherwise, mixed-effects Poisson
regression models were applied.
Graphical depictions of immunohistochemical outcomes
revealed that there was little variation among observations
from vehicle animals. Similarly, at day 21, observations in
DFP animals exhibited little to no variability. Hence, for
immunohistochemical outcomes, vehicle animals were
pooled across multiple days and used as the reference
group for day-specific DFP groups, with day 21 DFP data
dropped from the analysis. The treatment group factor for
the IHC outcomes thus had the following levels: vehicle
vs. day 1 DFP vs. day 2 DFP vs. day 3 DFP vs. day 7 DFP
vs. day 14 DFP. For these outcomes, mixed-effects models
were fit with the data to allow brain region-specific com-
parisons of day-specific DFP groups vs. the vehicle con-
trol, using main effects terms for the treatment group and
the brain region along with an interaction term for the
treatment group X brain region. These latter terms were
used in Wald tests to assess between-region heterogeneity
in pairwise comparisons among the treatment group fac-
tor levels. In case none was found, the model was simpli-
fied to a main effects only model.
For behavioral and TSPO imaging data, mixed-effects
regression models were used to estimate day-specific
comparisons between DFP and vehicle controls. Wald
tests for interaction were used similarly as above to as-
sess heterogeneity in DFP vs. vehicle contrasts by either
brain region (in the TSPO imaging data) or by day of
observation (for behavioral data). A two-way analysis of
variance (ANOVA) with Holm-Sidak multiple compari-
sons was used to assess differences in percent freezing
during context testing in DFP vs. vehicle rats over time.
Two-tailed Student’s t test was performed to compare
the locomotor activity of DFP and vehicle rats in the
open-field test.
Results
Acute DFP intoxication causes persistent neuronal
damage and neuroinflammation
Consistent with previous studies from our group [35]
and others [33, 36], ip injection with DFP at 9 mg/kg
following pretreatment with pyridostigmine and atropine
methyl nitrate (Fig. 1) caused severe seizure activity in
adult male Sprague Dawley rats in the absence of signifi-
cant mortality. To extend previous analyses of neuronal
cell injury up to 72 h following acute DFP intoxication
[35], FJB-labeled cells were quantified in multiple brain
regions of animals injected with a single dose of DFP or
saline (VEH) at 1, 2, 3, 7, 14, and 21 days post-injection.
Across all brain regions and time points examined, FJB
labeling was not detected in the brain sections from
VEH animals (Fig. 2). In contrast, in DFP animals, sig-
nificant numbers of FJB-labeled cells were observed at 1,
2, 3, 7, and 14 days post-exposure in the thalamus, CA1,
and dentate gyrus of the hippocampus and multiple re-
gions within the cortex (Fig. 2), and these effects were
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bilaterally symmetrical. However, in all of these brain re-
gions, FJB labeling returned to levels comparable to
those observed in VEH animals by 21 days post-DFP in-
jection. At no time point were FJB-labeled cells detected
in the cerebellum of DFP animals (data not shown).
To assess neuroinflammatory responses to acute DFP
intoxication, brain sections were immunostained for
GFAP, a marker of reactive astrocytes, and IBA1, a
marker of microglia. In both brain regions, reactive
astrogliosis and microglial activation were bilaterally
symmetrical. As illustrated in representative photomi-
crographs (Fig. 3a), relative to time- and region-matched
samples from VEH controls, acute intoxication with
DFP appeared to increase GFAP immunoreactivity at 1
and 7 days post-exposure in the hippocampus and cor-
tex. Quantification of GFAP immunoreactivity in these
brain regions indicated that DFP did not change the in-
tensity of GFAP immunofluorescence in either the
hippocampus or cortex (data not shown), but rather,
DFP significantly increased the area of GFAP immunore-
activity in both brain regions (Fig. 3a, b). In the hippo-
campus, DFP significantly increased the area of GFAP
immunoreactivity from 1 to 14 days post-injection with
peak labeling at 7 and 14 days post-injection. At 21 days
post-exposure, the area of GFAP immunoreactivity in
the hippocampus of DFP animals was significantly less
than that in VEH animals. DFP similarly increased the
area of GFAP immunoreactivity in the cortex at 1 day
post-exposure; however, unlike the hippocampus, the
area of GFAP immunoreactivity in the cortex remained
significantly increased at 21 days, with the maximal level
observed at 7 days post-exposure.
To further assess DFP-induced neuroinflammation,
the number and activation state of microglial cells were
evaluated. The area of IBA1 immunoreactivity was used
as an indicator of microglia number (Fig. 4), while
microglial cell morphology was used to assess the activa-
tion state of IBA1 immunopositive cells (Fig. 5). As
shown in representative micrographs (Fig. 4a), acute
DFP intoxication appeared to increase IBA1 immunore-
activity in both the hippocampus and cortex at 1 and
7 days post-injection. Quantification of IBA1 immunore-
activity in these brain regions indicated that DFP did not
change the intensity of IBA1 immunofluorescence in ei-
ther the hippocampus or cortex (data not shown); how-
ever, DFP increased the area of IBA1 immunoreactivity
in both brain regions. In the hippocampus, the area of
IBA1 immunoreactivity was significantly increased in
DFP relative to VEH animals at days 1 through 14 post-
exposure; however, at 21 days post-exposure, the area of
IBA1 immunoreactivity in the hippocampus was signifi-
cantly decreased in DFP animals relative to VEH con-
trols (Fig. 4b, c). In the cortex, DFP significantly
increased the area of IBA1 immunoreactivity at 2, 7, and
Fig. 2 Acute DFP intoxication causes persistent neuronal
degeneration in multiple brain regions. Rats injected with DFP
(9 mg/kg ip) or an equal volume (300 μl) of vehicle (VEH) were
euthanized at 1, 2, 3, 7, 14, and 21 days post-exposure to collect the
brains for FluoroJade-B (FJB) staining. a Representative photomicrographs
of FJB labeling in the thalamus (TH), CA1 region (CA1), and dentate gyrus
(DG) of the hippocampus, as well as somatosensory (SS), piriform (PF),
and entorhinal (ENT) cortices of the VEH and DFP-exposed rats at 7 days
post-injection. Bar= 50 μm. b Dot plots of the log number of FJB-labeled
cells in specific brain regions. Each dot represents the data from an
individual animal, while the horizontal gray bars represent the geometric
mean of FJB-labeled cells in that brain region at each time point. Note:
No FJB-labeled cells were detected in any brain region of any VEH animal
at any time point or in any DFP-exposed animals at 21 day post-
exposure; similarly, no FJB-labeled cells were detected in the thalamus
of one DFP-exposed animal at 2 days post-exposure, resulting in
a geometric mean of negative infinity for these conditions.
***Significantly different from VEH at p < .001
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Fig. 3 Acute DFP intoxication causes persistent astrogliosis in the
hippocampus and cortex. Rats injected with DFP (9 mg/kg ip) or an
equal volume (300 μl) of vehicle (VEH) were euthanized at 1, 2, 3, 7,
14, and 21 days post-exposure to collect the brains for GFAP
immunostaining. The area of GFAP immunoreactivity per field (three
fields per section in three sections per brain) was quantified in the
cortex and hippocampus as a measure of astrogliosis. a Representative
images of GFAP immunoreactivity in the hippocampus and cortex of
rats administered VEH or DFP at 1 and 7 days post-injection. Bar =
50 μm. b Dot plots of the log area of GFAP immunofluorescence in
the hippocampus and cortex, illustrating individual variation in GFAP
immunoreactivity within and between groups. Each dot represents the
data from an individual animal, while the horizontal gray bars represent
the geometric mean of the log area of GFAP immunofluorescence for
all animals at each time point. Note: VEH across all time points are
shown as one group because there were no significant time-
dependent differences between them. *Significantly different from VEH
at p < .05; **p < .01; ***p < .001. c Variation between experimental
groups is illustrated as the geometric mean ratio (dot) and 95 %
confidence interval (bar) of the area of GFAP immunofluorescence in
DFP-exposed rats relative to VEH controls. Confidence intervals not
overlapping y = 1 (gray horizontal bar) indicate a significant difference
between DFP and VEH conditions (p < .05)
Fig. 4 Acute DFP intoxication increases expression of the microglial
biomarker IBA1 in the hippocampus and cortex. Rats injected with DFP
(9 mg/kg ip) or an equal volume (300 μl) of vehicle (VEH) were
euthanized at 1, 2, 3, 7, 14, and 21 days post-exposure to collect the
brains for IBA1 immunostaining. The area of IBA1 immunoreactivity
per field (three fields per section in three sections per brain) was
quantified in the cortex and hippocampus to assess microglial activation.
a Representative photomicrographs of IBA1 immunoreactivity in the
hippocampus and cortex of rats administered VEH or DFP at 1 and
7 days post-injection. Bar = 50 μm. b Dot plots of the log area of
IBA1 immunofluorescence in the hippocampus and cortex. Each
dot represents the data from an individual animal while the horizontal
gray bars represent the geometric mean of the log area of IBA1
immunofluorescence for all animals at each time point. Note: VEH
across all time points are shown as one group because there were no
significant time-dependent differences between them. *Significantly
different from VEH at p < .05; **p < .01; ***p < .001. c The geometric
mean ratio (dot) and 95 % confidence interval (bar) of the area of IBA1
immunofluorescence in DFP-exposed rats relative to VEH controls.
Confidence intervals not overlapping y = 1 (gray horizontal bar) indicate
a significant difference between DFP and VEH conditions (p < .05)
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14 days post-exposure, but not at 1 or 3 days post-
exposure (Fig. 4b, c). At 21 days post-exposure, DFP
caused a significant decrease in IBA1 immunoreactivity
relative to VEH. Using morphological criteria to deter-
mine the activation state of microglia (Fig. 5a), DFP was
observed to cause multiple waves of microglial activation
in the hippocampus and cortex as evidenced by a signifi-
cant increase at 2 days, followed by a decrease to VEH
levels at 3 days, followed by a significant increase again
at 7 days post-exposure (Fig. 5b, c). In the hippocampus,
the second wave of microglia activation persisted to
21 days post-exposure whereas in the cortex, the num-
ber of activated microglia returned to VEH levels by
14 days post-exposure (Fig. 5b, c).
PET imaging of translocator protein 18 kDa (TSPO)
demonstrates delayed and persistent neuroinflammation
in DFP animals
PET imaging with the TSPO radioligand [11C]-(R)-
PK11195 was used as a second approach for assessing
neuroinflammation following acute DFP intoxication.
Images were obtained at day 0 (baseline) and at 2, 7, and
21 days post-exposure. MR images obtained from the
same animals at 7 or 14 days post-exposure were merged
with PET images for anatomic registration (Fig. 6a, b).
PET images showed that [11C]-(R)-PK11195 incorpor-
ation in the whole brain of VEH-treated rats was
minimal and did not change as a function of time post-
injection (Fig. 6c). In contrast, in DFP animals, whole
brain [11C]-(R)-PK11195 binding was detected at 2 days
and reached maximal binding at 7 days post-DFP injec-
tion (Fig. 6c). By 21 day post-exposure, [11C]-(R)-
PK11195 binding was decreased relative to 7 days but
was still noticeably above baseline.
Co-registration of MR and PET images enabled a more
accurate volume-of-interest drawing to quantify region-
specific changes in [11C]-(R)-PK11195 incorporation.
With the exception of 1 of 12 animals used in this study,
within any given brain, the patterns of change in TSPO
labeling over time were similar across multiple brain re-
gions (amygdala, dorsal lateral and medial dorsal thal-
amus, caudal and rostral hippocampus, piriform cortex,
somatosensory cortex, reuniens nucleus, and septum)
(Fig. 7). In the one exception, which was a DFP animal
(A23), three of the brain regions, the medial dorsal thal-
amus, reuniens nucleus, and septum, exhibited signifi-
cantly higher [11C]-(R)-PK11195 incorporation than the
other brain regions at 2 days post-exposure. Among all
VEH animals, there was little increase in [11C]-(R)-
PK11195 labeling (Fig. 7a) over the 21-day post-
exposure period. In contrast, among all the DFP animals,
there was heterogeneity in the pattern of TSPO labeling
over time. Most DFP animals exhibited a characteristic
TSPO-labeling phenotype with maximal [11C]-(R)-
PK11195 incorporation at 7 days post-exposure (Fig. 7b).
Interestingly, three DFP animals exhibited alternate
TSPO-labeling phenotypes (Fig. 7c). Two of these
showed negligible [11C]-(R)-PK11195 labeling over the
21-day post-exposure period while a third showed peak
labeling at 2 days post-exposure. Nevertheless, the geo-
metric mean ratio of [11C]-(R)-PK11195 incorporation
in DFP animals was still significantly increased relative
to VEH controls at 7 days even when animals with
Fig. 5 Acute DFP intoxication increases the number of activated
microglia in the hippocampus and cortex. a Representative
photomicrographs illustrating the morphology of resting vs.
activated IBA1 immunopositive microglia. Bar = 25 μm. b Dot plots
illustrating the log number of activated microglia per mm2 in the
hippocampus and cortex of VEH and DFP-exposed animals as a
function of days post-exposure. Each dot represents the data from
an individual animal, while the horizontal gray bars represent the
geometric mean for all brain sections at each time point. Note: VEH
across all time points are shown as one group because there were
no significant time-dependent differences between them. *Significantly
different from VEH at p < .05; **p < .01; ***p < .001. c Geometric mean
ratio (dot) and 95 % confidence interval (bar) of the number of
activated microglia in DFP-exposed rats relative to VEH. Confidence
intervals not overlapping y = 1 (gray horizontal bar) indicate a
significant difference relative to VEH (p < .05)
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“alternate” TSPO phenotypes were included in the stat-
istical analyses (Fig. 8a).
To investigate a potential explanation for the alternate
TSPO phenotypes observed in a subset of DFP animals,
the relationship between [11C]-(R)-PK11195 binding and
seizure severity was investigated. DFP animals expressing
alternate TSPO phenotypes had a lower maximal seizure
score relative to those rats displaying the predominant
TSPO phenotype (Fig. 8b).
Acute DFP intoxication leads to persistent learning and
memory deficits
Contextual fear conditioning was used to assess the effects
of acute DFP intoxication on learning and memory. An
initial cohort of animals was tested using a three-shock
conditioning paradigm with a 0.75-mA foot shock.
Animals were conditioned on days 2, 6, 13, and 35 post-
DFP or vehicle exposure. Analysis of baseline and post-
conditioning freezing behavior identified no significant
differences between VEH and DFP animals (Fig. 9a),
indicating that both DFP and VEH animals responded to
the CS as expected (F(1, 12) = 66.44, p < .001). Analysis of
freezing behavior during the context test 24 h later re-
vealed a significant effect of treatment across time (F(3, 30)
= 3.3587, p < .05). Holm-Sidak post hoc testing indicated
that DFP animals froze significantly less than VEH at
36 days post-exposure (Fig. 9b). Testing of these animals
in the open-field test at 7 days post-exposure indicated
that acute DFP intoxication did not alter locomotor be-
havior (Fig. 9c), suggesting that the differences in freezing
behavior noted in the contextual fear-conditioning test are
not due to effects of DFP on locomotor behavior.
A second cohort of animals was tested using a single-
shock conditioning paradigm. The goal was to determine
whether cognitive deficits would manifest at an earlier
time post-exposure, which would be desirable for longi-
tudinal monitoring of neuroinflammation by PET im-
aging of the same animals subjected to behavioral
testing. For this second study, DFP and VEH animals
were conditioned on days 3, 8, and 19 post-exposure
Fig. 6 TSPO PET imaging detects neuroinflammation in DFP-intoxicated rats. TSPO expression was quantified in rats injected with the TSPO ligand
[11C]-PK11195. All animals were imaged before administration of VEH or DFP to collect baseline TSPO labeling; the same animals were imaged
again at 2, 7, and 21 days post-injection with VEH or DFP. a Representative magnetic resonance image (MRI) was used for anatomic registry of
PET images. b Overlay of MRI and [11C]-PK11195 PET data for an animal with typical response at baseline and at 7 days post-DFP intoxication.
c Longitudinal comparison of [11C]-PK11195 uptake in a VEH (top row) vs. DFP-intoxicated animal (bottom row). Note: For the seventh day
images, the upper limit of the color scale for PET imaging is increased to reflect a larger dynamic range of [11C]-PK11195 uptake values at
this time point. %ID/cc percent injected dose per cc
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using a single CS-US-paired stimulus with a 0.5-mA foot
shock. A subset of these animals was imaged by PET on
days 2, 7, and 21. Analysis of freezing behavior during
the context test within the entire cohort (imaged and
non-imaged animals) revealed a significant effect of
treatment (F(1, 24) = 30.41, p < .001) and testing (F(2, 48) =
17.93, p = .001) and an interaction between treatment
and day (F(2, 48) = 10.87, p = .0001). Holm-Sidak post hoc
testing indicated that DFP animals froze significantly less
than VEH at 9 days (p < .01) and 20 days (p < .05) post-
exposure, indicating that DFP animals did not remember
the context of the CS-US pairing as well as the VEH
controls (Fig. 10a). DFP and VEH animals exhibited
similar levels of freezing during the context test at 4 days
post-exposure (Fig. 10a). Analysis of the subset of
imaged animals also revealed a significant interaction
between treatment and day (F(2,17) = 26.69, p < .001).
Holm-Sidak post hoc testing indicated that DFP animals
froze significantly less than VEH at 9 days (p < .001) and
20 days (p < .001) post-exposure but that there was no
difference between the groups at 4 days post-exposure
(Fig. 10b). Careful analysis of video recordings from both
cohorts of animals by two individuals blinded to the
experimental group revealed no evidence of seizure be-
havior in DFP animals during the CS-US pairing or the
context testing.
As an initial assessment of a possible relationship
between neuroinflammation and impaired learning and
memory, freezing behavior was assessed as a function of
TSPO phenotype in the subset of animals that under-
went both PET imaging of TSPO and behavioral testing
(Fig. 10c). At 4 and 9 days post-exposure, the % time
Fig. 7 Patterns of TSPO labeling in VEH vs. DFP-intoxicated rats. Rats injected with the TSPO ligand [11C]-PK11195 were imaged prior to administration
of VEH or DFP (day 0) and again at 2, 7, and 21 days post-exposure. Each plot represents an individual rat (with a unique identifier shown at the top of
the plot) and each line within a plot represents a separate brain region (amygdala, dorsal lateral and medial dorsal thalamus, caudal and rostral
hippocampus, piriform cortex, somatosensory cortex, reuniens nucleus, and septum). a The TSPO expression pattern for three VEH rats. b The
predominant TSPO expression pattern imaged in DFP-intoxicated animals (six of nine) showing a predominant peak in TSPO labeling at 7 days
post-exposure. Animal A08 died after baseline imaging, within hours after the DFP injection, and animal A03 died several days after the seventh day
imaging. c Alternate TSPO expression phenotypes observed in three of the nine DFP-exposed rats. %ID/CC percent of injected dose per cc
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spent freezing by DFP animals was similar between the
predominant and alternate TSPO phenotypes. At 20 days
post-exposure, the % time spent freezing appeared to be
slightly less in the predominant vs. the alternate TSPO
phenotype. Logistic regression analyses of context-
testing outcomes revealed statistically significant com-
parisons (vs. VEH controls) in the DFP animals such
that VEH controls learned to associate the context with
a foot shock over time, while DFP-treated rats did not
(Fig. 10d). At 4 days post-exposure, VEH and DFP ani-
mals exhibited similar percent freezing during the
context test (4-day DFP vs. VEH AOR = 1.42, 95 % CI
0.43–4.7; p = .52); however, at 9 and 20 days post-
exposure, DFP animals exhibited much less freezing
compared to VEH controls (AOR at day 9 = 0.07, 95 %
CI 0.02–0.21, p < .001; AOR at day 20 = 0.07, 95 % CI
0.02, 0.27, p < .001). Excluding DFP animals exhibiting
alternate TSPO phenotypes from the statistical analyses
did not significantly change the results (Fig. 10d).
Fig. 8 TSPO expression is persistently upregulated in DFP-
intoxicated animals that experience more severe seizures. a The
geometric mean ratio (dot) of TSPO labeling with 95 % confidence
interval (bar) in DFP-exposed rats relative to VEH controls. Confidence
intervals not overlapping y = 1 (gray horizontal bar) indicate a
significant difference relative to VEH (p < .05). The data presented
in the left panel include all TSPO phenotypes (n = 9 DFP-exposed
animals as shown in Fig. 7), while the data presented in the right
panel exclude the three DFP-intoxicated animals expressing the
alternate TSPO phenotypes, as shown in Fig. 7. b The predominant
TSPO expression phenotype is highly associated with more severe
seizure behavior as indicated by higher seizure scores (p < .01 as
determined using the Wilcoxon signed rank test)
Fig. 9 Acute DFP intoxication causes delayed learning and memory
deficits without changing locomotor activity. a Animals were
conditioned 2, 6, 13, and 35 days post-exposure using a three-
shock conditioning paradigm with foot shocks at 0.7 mA every
30 s. b Animals were tested 24 h later for hippocampal-dependent
contextual learning and memory. Data presented as mean ± SD (N = 6
per treatment group). *Significantly different from VEH on the same-
day post-exposure (p < .05) as determined by two-way ANOVA
followed by Holm-Sidak post hoc test. c Locomotor activity was
quantified during a 15-min open-field test at 7 days post-exposure in
DFP-intoxicated and vehicle control animals. Data presented as the
mean ± SD (N = 5 per group). No significant differences between
groups were identified using two-tailed Student’s t test
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Discussion
Previous studies have demonstrated that in adult male
rats, an acute exposure to a seizure-inducing dose of DFP
triggers a robust neuroinflammatory response during the
first few days post-exposure that coincides spatially and
temporally with extensive neurodegeneration in multiple
brain regions [31–36, 50]. Deficits in spatial learning [38]
or memory [39], as well as depression-relevant behavior
[40], have also been reported in the weeks following an
acute exposure to DFP at this same dose [39] or doses that
cause cholinergic toxicity, but not necessarily seizure be-
havior [38, 40]. Our findings extend these previous obser-
vations by demonstrating that the neuroinflammatory and
neurodegenerative responses to acute DFP-induced SE
persist beyond the initial few days post-exposure. Add-
itionally, data obtained using PET imaging of the TSPO
ligand [11C]-(R)-PK11195 to monitor neuroinflammation
in the same animal over time indicate a positive correl-
ation between seizure severity and TSPO labeling in the
whole brain. However, a strong correlation between these
outcomes and DFP-induced deficits in learning and mem-
ory was not observed.
Acute intoxication with DFP was observed to cause
moderate-to-severe seizure activity in rats, consistent
with a previous report demonstrating that this same
DFP-dosing paradigm triggers electrographic SE in adult
Fig. 10 Cognitive deficits are not strongly associated with TSPO labeling. a DFP and VEH animals were conditioned 3, 8, and 19 days post-
exposure using a single paired shock conditioning paradigm with foot shocks at 0.5 mA and then tested 24 h later for hippocampal-dependent
contextual learning and memory (N = 10 VEH and 16 DFP-exposed animals). b Data from contextual fear conditioning in the subset of animals
(N = 3 VEH and 6 DFP-exposed animals) also imaged by PET at 2, 7, and 21 days post-exposure. Data presented as the mean ± SD. *Significantly
different from VEH on the same-day post-exposure as determined by two-way ANOVA followed by Holm-Sidak post hoc test at p < .05;
**p < .01; ***p < .001. c Patterns of freezing behavior as a function of days post-exposure across different treatments and TSPO phenotypes,
as described in Fig. 7. Each line represents the data from a single animal. d Adjusted odds ratio of freezing behavior in DFP-intoxicated
rats relative to VEH with 95 % confidence interval. Confidence intervals not overlapping y = 1 (horizontal gray bar) indicate a significant
difference relative to VEH (p < .05)
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male Sprague Dawley rats [39]. It has been previously
reported that intense neuronal activity and seizures [51],
including SE induced by OP nerve agents [16–18] or OP
pesticides [31–34], rapidly activate astrocytes and micro-
glia. Consistent with these reports, acute DFP intoxication
caused a rapid and robust neuroinflammatory response in
the hippocampus and cortex comprised of reactive astro-
gliosis, as evidenced by significantly increased GFAP im-
munoreactivity, and microglial activation, as determined
using morphological criteria to assess the activational sta-
tus of IBA1 immunopositive cells. In both brain regions,
reactive astrogliosis preceded microglial activation, al-
though there was an apparent increase in microglial cell
number coincident with initial astrocyte activation. In
contrast to previous studies of acute DFP intoxication that
terminated at 7 days post-exposure [31] or earlier [32–34,
36], we quantified astrogliosis and microglial cell activa-
tion out to 21 days post-exposure. While neuroinflamma-
tion persisted in both brain regions beyond 7 days post-
exposure, the temporal profile was region dependent.
Reactive astrogliosis persisted significantly longer in the
cortex relative to the hippocampus, and while a second
wave of microglial activation was apparent in both brain
regions at 7 days post-exposure, this persisted significantly
longer in the hippocampus relative to the cortex. Whether
the second wave of apparent microglial cell activation rep-
resents microglia and/or monocytes recruited from the
periphery remains to be determined. Also unknown at this
time is whether the neuroinflammatory response triggered
by acute DFP intoxication worsens after 21 days post-
exposure, as has been reported following acute intoxica-
tion with OP nerve agents [4, 30]. Both questions are the
focus of ongoing research.
In general concurrence with immunohistochemical
evidence of neuroinflammation, PET imaging of TSPO
labeling in the brains of DFP-intoxicated rats indicated
that the majority (six of nine animals) exhibited signifi-
cantly increased neuroinflammation in the hippocampus
and cortex relative to baseline pre-exposure values in
DFP animals and relative to VEH controls at 2, 7, and
21 days. Peak [11C]-(R)-PK11195 binding was observed
at 7 days post-exposure. However, a subset of animals
(three of nine) exhibited an alternate phenotype in which
there was either no significant change in binding of
[11C]-(R)-PK11195 relative to pre-exposure baseline at
any of the imaging times post-exposure or, in the case of
one animal, a significant increase in TSPO labeling at
2 days post-exposure that returned to baseline pre-
exposure levels by 7 days post-exposure. Evaluation of
the maximal seizure score observed among all nine DFP
animals during the first 4 h post-DFP injection indicated
that the animals with the alternate TSPO phenotype had
less severe seizures than animals exhibiting the predom-
inant TSPO phenotype. These data strongly suggest that
neuroinflammation is positively correlated with seizure
severity. This is consistent with previous observations of
a positive correlation between seizure severity and in-
creased expression of neuronal cyclooxygenase 2 in the
hippocampus, amygdala, piriform cortex, and thalamus
of rats acutely intoxicated with the OP nerve agent
soman [18].
In experimental models of SE induced by OP nerve
agents, the early neuroinflammatory responses typically
coincide with neurodegeneration (reviewed in [3–5, 12]).
Similarly, we detected significant neurodegeneration
during the first 3 days post-exposure in multiple brain
regions, including the hippocampus and cortex, as evi-
denced by an increased number of FJB-labeled cells,
which we previously identified as neurons [35]. In all the
brain regions examined, the number of FJB-labeled
neurons remained elevated at 7 and 14 days post-
exposure but decreased to control levels by 21 days
post-exposure. In the hippocampus, neurodegeneration
coincided with reactive astrogliosis but ended prior to
the decrease in microglial cell activation. In contrast, in
the cortex, reactive astrogliosis persisted beyond the
period of neurodegeneration, while microglial cell activa-
tion returned to control levels prior to the end of the
neurodegenerative period. These observations raise in-
teresting questions regarding the relationship between
neuroinflammation and neurodegeneration in acute DFP
intoxication. In previous studies of this model, we ob-
served significantly increased GFAP immunoreactivity in
the piriform cortex, amygdala, and dentate gyrus at 1 h
post-DFP exposure [31], at which time we saw no evi-
dence of neuronal cell death in these brain regions [35],
suggesting that the initial activation of astrocytes occurs
independent of neurodegeneration. In experimental
models of acute soman intoxication, microglial activation
follows an early increase in GFAP immunoreactivity and
precedes neuronal injury, suggesting that soman-induced
SE induces astrogliosis resulting in a neuroinflammatory
response that contributes to neuronal injury [16, 52].
However, a study suggesting that delayed astrogliosis me-
diates synaptic plasticity and neuronal repair in mice
acutely intoxicated with soman [53] supports the model of
a dynamic relationship between neurodegeneration and
neuroinflammation that changes over time.
Persistent memory impairment is one of the most
common behavioral consequences observed in humans
who survive acute OP poisoning [5]. Years after the
1995 Tokyo subway attack with sarin, exposed rescue
personnel and subway workers exhibited significant
deficits on memory tests compared to non-exposed
control subjects [54, 55]. OP-induced SE has also been
shown to impair memory in preclinical models [38, 39,
56, 57]. Consistent with these reports, we observed that
DFP-induced SE significantly impaired performance in
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contextual fear conditioning at 9 and 20 days post-
exposure. These data corroborate a recent publication
reporting that rats intoxicated with DFP, using the same
dosing paradigm used here, exhibited impaired perform-
ance in the novel object recognition task [39]. Surpris-
ingly, however, cognitive deficits in DFP-intoxicated rats
did not vary according to TSPO phenotype or seizure se-
verity score. Specifically, a subset of DFP-intoxicated ani-
mals with moderate seizure severity scores and either
minimal or early, but non-persistent, TSPO labeling as de-
termined by PET imaging exhibited deficits in the con-
textual fear-conditioning task that were comparable to
those of DFP-intoxicated animals with high seizure sever-
ity scores and significant TSPO labeling at all three post-
exposure imaging times. This observation suggests that
acute DFP intoxication causes cognitive deficits inde-
pendent of seizure activity and neuroinflammation. Al-
ternative mechanisms of OP neurotoxicity that may be
relevant include cholinergic excitotoxicity [5], oxidative
stress [50, 58], and impaired microtubule function [59].
While our data suggest that neither seizure severity
nor neuroinflammation is the primary determinant of
DFP-induced cognitive deficits, several important ca-
veats support the need for further studies to confirm
this interpretation. First, since the animals could not be
instrumented to collect electrographic data, we cannot
rule out the possibility that the subset of animals with
the lower maximal seizure severity scores experienced
seizures of longer duration such that their “average”
seizure score over time may be equivalent to that of the
animals with the higher maximal seizure severity
scores. If this were the case, based on data indicating
that the duration of seizure activity is a predominant
determinant of pathological outcome following acute
intoxication with OP nerve agents [11], it would not be
surprising that the two groups of DFP animals exhib-
ited comparable deficits in cognitive behavior. Alterna-
tively, it may be that the influence of seizure activity on
cognitive behavior is not a linear correlation in which
seizures of greater intensity and/or duration cause pro-
portionately more severe behavioral deficits, but rather,
there is a threshold level of neural damage required to
elicit behavioral deficits. In this case, the moderate seiz-
ure behavior experienced by the DFP animals exhibiting
the alternative TSPO phenotype may have generated
sufficient neural damage to cross this threshold. Sec-
ond, because PET imaging was only performed at 2, 7,
and 21 days post-exposure, it is possible that we missed
an increase in TSPO labeling that occurred between
these imaging days in the group of animals with the alter-
nate TSPO phenotype. Third, because the PET imaging
and immunocytochemical studies of neuroinflammation
were performed in separate cohorts of animals, we cannot
determine the extent to which [11C]-(R)-PK11195 labels
activated microglia vs. reactive astrocytes. This may be an
important consideration in light of a recent report that an
inhibitor of the prostaglandin E2 receptor EP2, which sig-
nificantly decreases microglial activation but not reactive
astrogliosis during the first few days following acute in-
toxication with DFP [34], was also effective in attenuating
deficits in the novel object recognition task [39]. These
findings suggest that microglial activation, but not reactive
astrogliosis, is causally linked to memory impairment fol-
lowing OP-induced SE. This remains to be proven; how-
ever, if true, it will be important to determine whether the
TSPO signal in our PET imaging data is due predomin-
antly to binding of [11C]-(R)-PK11195 by astrocytes or
microglia. If the PET signal is driven primarily by the
astrocytic expression of TSPO, PET imaging of [11C]-(R)-
PK11195 binding may have missed more subtle, but func-
tionally significant, increases in microglial activation. It
will also be important to confirm our semi-quantitative
assessments of reactive astrogliosis and microglial activa-
tion by immunocytochemistry and PET imaging using
western blotting or ELISA. Last, a key feature of altered
cognition associated with neuroinflammation is the al-
tered expression of proinflammatory cytokines and che-
mokines. These factors were not examined in the present
study; thus, the observed lack of correlation between
GFAP and IBA1 immunoreactivity with impaired per-
formance in contextual fear conditioning does not defini-
tively rule out a role for neuroinflammation in the
pathogenesis of DFP-induced cognitive deficits.
Conclusions
We describe a preclinical model in which acute DFP in-
toxication causes seizures, persistent neuroinflammation,
and cognitive deficits. The extent of the neuroinflamma-
tory response is influenced by seizure severity. However,
the observation that a subset of animals with moderate
seizures and minimal TSPO labeling exhibited cognitive
deficits comparable to those of animals with severe sei-
zures and significant TSPO labeling raises questions as
to the role of both seizures and neuroinflammation in
the pathogenesis of cognitive dysfunction following
acute OP intoxication. Collectively, these findings, to-
gether with previous reports suggesting that microglial
activation, but not reactive astrogliosis, is linked to DFP-
induced memory impairment [34, 39] and that delayed
astrogliosis enhances neurogenesis and accelerates func-
tional recovery of affective, but not cognitive, behavior
[53], suggest that the role of neuroinflammation likely
changes post-exposure as the profile of neuroinflamma-
tory cell activation evolves. Further, these observations
suggest that the influence of neuroinflammation is likely
to vary across the diverse neurological outcomes associ-
ated with acute OP intoxication.
Flannery et al. Journal of Neuroinflammation  (2016) 13:267 Page 14 of 16
Abbreviations
DFP: Diisopropylfluorophosphate; FJB: FluoroJade-B; GFAP: Glial fibrillary
acidic protein; IBA1: Ionized calcium-binding adapter molecule 1;
OP: Organophosphorus; PET: Positron emission tomography; SE: Status
epilepticus; TSPO: Translocator protein
Acknowledgements
We thank Jennifer Fung and Michelle Connell (UC Davis) for technical
contributions to the PET imaging studies and Joel Garbow (Washington
University in Saint Louis) for providing helpful feedback on the manuscript.
Funding
This work was supported by the CounterACT Program, National Institutes
of Health Office of the Director, and the National Institute of Neurological
Disorders and Stroke (U54 NS079202 to PJL and U01 NS057993 to BDF)
and by the National Institute of Environmental Health Sciences (T32
ES007059 to CNB). The sponsors were not involved in the study design
and the collection, analysis, or interpretation of the data; in the writing of
the report; or in the decision to submit the paper for publication.
Availability of data and materials
All the data generated and analyzed during the current study are available
from the corresponding author on reasonable request.
Authors’ contributions
PJL conceived of the study, participated in its design and oversaw its
coordination, contributed to the data interpretation, and contributed
significantly to the writing of the manuscript. BMF collected the open-field
test data, participated in the analysis of all the behavioral data, generated
the initial figures for the manuscript, and wrote the first draft of the
manuscript. DAB dosed the animals, collected the seizure data, performed
and analyzed the FluoroJade-B-labeling experiments and contextual fear-
conditioning experiments, and helped with the in vivo imaging experiments
and drafting of the manuscript. DJR designed the in vivo imaging experiments,
collected and analyzed the PET and MRI data, and helped to draft the
manuscript. CNB performed and analyzed the immunohistochemical
experiments. ATA and DJT performed the statistical analyses and helped to
draft the manuscript. DLK synthesized [11C]-(R)-PK11195, which included
modifying a previously published protocol, and helped to draft the manuscript.
YL helped with the analysis of the in vivo imaging data. BDF participated in the
design of the study. JLS helped with the design and analysis of the behavioral
data and with the drafting of the manuscript. SRC helped with the design and
analysis of the in vivo imaging data. All authors read and approved of the final
manuscript.
Competing interests




All studies involving animals were performed with regard for alleviation of
pain and suffering under protocols approved by the UC Davis Institutional
Animal Care and Use Committee.
Author details
1Department of Molecular Biosciences, School of Veterinary Medicine,
University of California-Davis, Davis, CA, 95616, USA. 2Center for Molecular
and Genomic Imaging, University of California-Davis, Davis, CA 95616, USA.
3Department of Pediatrics, University of California-Davis Medical Center,
Sacramento, CA 95817, USA. 4Division of Biomedical Sciences, University of
California-Riverside School of Medicine, Riverside, CA 92521, USA.
5Department of Psychiatry and Behavioral Sciences, University of
California-Davis Medical Center, Sacramento, CA 95817, USA. 6Current
address: Office of Environmental Health Hazard Assessment, California
Environmental Protection Agency, Sacramento, CA 95812, USA. 7Current
address: Navistar, Inc., 2701 Navistar Drive, Lisle, IL 60532, USA.
Received: 22 August 2016 Accepted: 6 October 2016
References
1. Gunnell D, Eddleston M. Suicide by intentional ingestion of pesticides: a
continuing tragedy in developing countries. Int J Epidemiol. 2003;32(6):902–9.
2. Jett DA. Neurological aspects of chemical terrorism. Ann Neurol. 2007;
61(1):9–13.
3. Pereira EF, Aracava Y, DeTolla Jr LJ, Beecham EJ, Basinger Jr GW, Wakayama
EJ, Albuquerque EX. Animal models that best reproduce the clinical
manifestations of human intoxication with organophosphorus compounds.
J Pharmacol Exp Ther. 2014;350(2):313–21.
4. Collombet JM. Nerve agent intoxication: recent neuropathophysiological
findings and subsequent impact on medical management prospects.
Toxicol Appl Pharmacol. 2011;255(3):229–41.
5. Chen Y. Organophosphate-induced brain damage: mechanisms,
neuropsychiatric and neurological consequences, and potential therapeutic
strategies. Neurotoxicology. 2012;33(3):391–400.
6. Eddleston M, Phillips MR. Self poisoning with pesticides. BMJ. 2004;
328(7430):42–4.
7. Eddleston M, Buckley NA, Eyer P, Dawson AH. Management of acute
organophosphorus pesticide poisoning. Lancet. 2008;371(9612):597–607.
8. Worek F, Thiermann H. The value of novel oximes for treatment of
poisoning by organophosphorus compounds. Pharmacol Ther. 2013;
139(2):249–59.
9. Okumura T, Hisaoka T, Yamada A, Naito T, Isonuma H, Okumura S,
Miura K, Sakurada M, Maekawa H, Ishimatsu S, et al. The Tokyo
subway sarin attack—lessons learned. Toxicol Appl Pharmacol.
2005;207(2 Suppl):471–6.
10. UN Secretary General Report: United Nations mission to investigate
allegations of the use of chemical weapons in the Syrian Arab Republic.
Report on the allege use of chemical weapons in the Ghouta Area of
Damascus on 21 Aug 2013. [https://syriagenerals.wordpress.com/must-read-
documents/chemical-weapons-resource-page/]
11. Shih TM, Duniho SM, McDonough JH. Control of nerve agent-induced
seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol.
2003;188(2):69–80.
12. de Araujo FM, Rossetti F, Chanda S, Yourick D. Exposure to nerve agents:
from status epilepticus to neuroinflammation, brain damage, neurogenesis
and epilepsy. Neurotoxicology. 2012;33(6):1476–90.
13. Banks CN, Lein PJ. A review of experimental evidence linking neurotoxic
organophosphorus compounds and inflammation. Neurotoxicology. 2012;
33(3):575–84.
14. Cowan FM, Broomfield CA, Lenz DE, Smith WJ. Putative role of proteolysis
and inflammatory response in the toxicity of nerve and blister chemical
warfare agents: implications for multi-threat medical countermeasures. J
Appl Toxicol. 2003;23:177–86.
15. Cowan FM, Broomfield CA, Stojiljkovic MP, Smith WJ. A review of multi-
threat medical countermeasures against chemical warfare and terrorism. Mil
Med. 2004;169(11):850–5.
16. Zimmer LA, Ennis M, Shipley MT. Soman-induced seizures rapidly activate
astrocytes and microglia in discrete brain regions. J Comp Neurol. 1997;
378(4):482–92.
17. Collombet JM, Four E, Bernabe D, Masqueliez C, Burckhart MF, Baille V,
Baubichon D, Lallement G. Soman poisoning increases neural progenitor
proliferation and induces long-term glial activation in mouse brain.
Toxicology. 2005;208(3):319–34.
18. Angoa-Perez M, Kreipke CW, Thomas DM, Van Shura KE, Lyman M,
McDonough JH, Kuhn DM. Soman increases neuronal COX-2 levels: possible
link between seizures and protracted neuronal damage. Neurotoxicology.
2010;31(6):738–46.
19. Zaja-Milatovic S, Gupta RC, Aschner M, Milatovic D. Protection of DFP-
induced oxidative damage and neurodegeneration by antioxidants and
NMDA receptor antagonist. Toxicol Appl Pharmacol. 2009;240(2):124–31.
20. Dhote F, Peinnequin A, Carpentier P, Baille V, Delacour C, Foquin A,
Lallement G, Dorandeu F. Prolonged inflammatory gene response following
soman-induced seizures in mice. Toxicology. 2007;238(2-3):166–76.
21. Dillman 3rd JF, Phillips CS, Kniffin DM, Tompkins CP, Hamilton TA, Kan
RK. Gene expression profiling of rat hippocampus following exposure
to the acetylcholinesterase inhibitor soman. Chem Res Toxicol.
2009;22(4):633–8.
22. Chapman S, Kadar T, Gilat E. Seizure duration following sarin exposure
affects neuro-inflammatory markers in the rat brain. Neurotoxicology. 2006;
27(2):277–83.
Flannery et al. Journal of Neuroinflammation  (2016) 13:267 Page 15 of 16
23. Johnson EA, Kan RK. The acute phase response and soman-induced status
epilepticus: temporal, regional and cellular changes in rat brain cytokine
concentrations. J Neuroinflammation. 2010;7:40.
24. Svensson I, Waara L, Johansson L, Bucht A, Cassel G. Soman-induced interleukin-
1 beta mRNA and protein in rat brain. Neurotoxicology. 2001;22(3):355–62.
25. Williams AJ, Berti R, Yao C, Price RA, Velarde LC, Koplovitz I, Schultz SM,
Tortella FC, Dave JR. Central neuro-inflammatory gene response following
soman exposure in the rat. Neurosci Lett. 2003;349(3):147–50.
26. Pope CN. Organophosphorus pesticides: do they all have the same
mechanism of toxicity? J Toxicol Environ Health B Crit Rev. 1999;2(2):161–81.
27. Costa LG. Current issues in organophosphate toxicology. Clin Chim Acta.
2006;366(1-2):1–13.
28. Rosenbaum C, Bird SB. Non-muscarinic therapeutic targets for acute
organophosphorus poisoning. J Med Toxicol. 2010;6(4):408–12.
29. Damodaran TV, Abou-Donia MB. Alterations in levels of mRNAs coding for
glial fibrillary acidic protein (GFAP) and vimentin genes in the central
nervous system of hens treated with diisopropyl phosphorofluoridate (DFP).
Neurochem Res. 2000;25(6):809–16.
30. Grauer E, Chapman S, Rabinovitz I, Raveh L, Weissman BA, Kadar T, Allon N.
Single whole-body exposure to sarin vapor in rats: long-term neuronal and
behavioral deficits. Toxicol Appl Pharmacol. 2008;227(2):265–74.
31. Liu C, Li Y, Lein PJ, Ford BD. Spatiotemporal patterns of GFAP upregulation
in rat brain following acute intoxication with diisopropylfluorophosphate
(DFP). Curr Neurobiol. 2012;3(2):90–7.
32. Li Y, Lein PJ, Ford GD, Liu C, Stovall KC, White TE, Bruun DA, Tewolde T,
Gates AS, Distel TJ, et al. Neuregulin-1 inhibits neuroinflammatory responses
in a rat model of organophosphate-nerve agent-induced delayed neuronal
injury. J Neuroinflammation. 2015;12:64.
33. Ferchmin PA, Andino M, Reyes Salaman R, Alves J, Velez-Roman J, Cuadrado
B, Carrasco M, Torres-Rivera W, Segarra A, Martins AH, et al. 4R-cembranoid
protects against diisopropylfluorophosphate-mediated neurodegeneration.
Neurotoxicology. 2014;44:80–90.
34. Rojas A, Ganesh T, Lelutiu N, Gueorguieva P, Dingledine R. Inhibition of the
prostaglandin EP2 receptor is neuroprotective and accelerates functional
recovery in a rat model of organophosphorus induced status epilepticus.
Neuropharmacology. 2015;93:15–27.
35. Li Y, Lein PJ, Liu C, Bruun DA, Tewolde T, Ford G, Ford BD. Spatiotemporal
pattern of neuronal injury induced by DFP in rats: a model for delayed
neuronal cell death following acute OP intoxication. Toxicol Appl
Pharmacol. 2011;253(3):261–9.
36. Kim YB, Hur GH, Shin S. Organophosphate-induced brain injuries: delayed
apoptosis mediated by nitric oxide. Environ Toxicol Pharmacol. 1999;7:147–52.
37. Kadriu B, Gocel J, Larson J, Guidotti A, Davis JM, Nambiar MP, Auta J.
Absence of tolerance to the anticonvulsant and neuroprotective effects of
imidazenil against DFP-induced seizure and neuronal damage.
Neuropharmacology. 2011;61(8):1463–9.
38. Brewer KL, Troendle MM, Pekman L, Meggs WJ. Naltrexone prevents
delayed encephalopathy in rats poisoned with the sarin analogue
diisopropylflurophosphate. Am J Emerg Med. 2013;31(4):676–9.
39. Rojas A, Ganesh T, Manji Z, O’Neill T, Dingledine R. Inhibition of the
prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits
in the novel object recognition task in rats. Neuropharmacology. 2016;
110(Pt A):419–30.
40. Wright LK, Liu J, Nallapaneni A, Pope CN. Behavioral sequelae following
acute diisopropylfluorophosphate intoxication in rats: comparative effects of
atropine and cannabinomimetics. Neurotoxicol Teratol. 2010;32(3):329–35.
41. Raybuck JD, Lattal KM. Double dissociation of amygdala and hippocampal
contributions to trace and delay fear conditioning. PloS One. 2011;6(1):e15982.
42. de Araujo FM, Lumley LA, Robison C, Tong LC, Lichtenstein S, Yourick DL.
Spontaneous recurrent seizures after status epilepticus induced by soman in
Sprague-Dawley rats. Epilepsia. 2010;51(8):1503–10.
43. Veiga S, Carrero P, Pernia O, Azcoitia I, Garcia-Segura LM. Translocator
protein 18 kDa is involved in the regulation of reactive gliosis. Glia. 2007;
55(14):1426–36.
44. Lavisse S, Guillermier M, Herard AS, Petit F, Delahaye M, Van Camp N, Ben
Haim L, Lebon V, Remy P, Dolle F, et al. Reactive astrocytes overexpress
TSPO and are detected by TSPO positron emission tomography imaging. J
Neurosci. 2012;32(32):10809–18.
45. Shih TM, Koviak TA, Capacio BR. Anticonvulsants for poisoning by the
organophosphorus compound soman: pharmacological mechanisms.
Neurosci Biobehav Rev. 1991;15(3):349–62.
46. Deshpande LS, Carter DS, Blair RE, DeLorenzo RJ. Development of a
prolonged calcium plateau in hippocampal neurons in rats surviving status
epilepticus induced by the organophosphate diisopropylfluorophosphate.
Toxicol Sci. 2010;116(2):623–31.
47. Zolkowska D, Banks CN, Dhir A, Inceoglu B, Sanborn JR, McCoy MR, Bruun
DA, Hammock BD, Lein PJ, Rogawski MA. Characterization of seizures
induced by acute and repeated exposure to
tetramethylenedisulfotetramine. J Pharmacol Exp Ther. 2012;341(2):435–46.
48. Matthews MA, Kruger L. Electron microscopy of non-neuronal cellular
changes accompanying neural degeneration in thalamic nuclei of the
rabbit. II. Reactive elements within the neuropil. J Comp Neurol. 1973;148(3):
313–46.
49. Kannan S, Saadani-Makki F, Muzik O, Chakraborty P, Mangner TJ, Janisse J,
Romero R, Chugani DC. Microglial activation in perinatal rabbit brain
induced by intrauterine inflammation: detection with 11C-(R)-PK11195 and
small-animal PET. J Nucl Med. 2007;48(6):946–54.
50. Li Y, Lein PJ, Liu C, Bruun DA, Giulivi C, Ford GD, Tewolde T, Ross-Inta C,
Ford BD. Neuregulin-1 is neuroprotective in a rat model of
organophosphate-induced delayed neuronal injury. Toxicol Appl Pharmacol.
2012;262(2):194–204.
51. Steward O, Torre ER, Tomasulo R, Lothman E. Neuronal activity up-regulates
astroglial gene expression. Proc Natl Acad Sci U S A. 1991;88(15):6819–23.
52. Baille-Le Crom V, Collombet JM, Carpentier P, Brochier G, Burckhart MF,
Foquin A, Pernot-Marino I, Rondouin G, Lallement G. Early regional changes
of GFAP mRNA in rat hippocampus and dentate gyrus during soman-
induced seizures. Neuroreport. 1995;7(1):365–9.
53. Collombet JM, Beracochea D, Liscia P, Pierard C, Lallement G, Filliat P. Long-
term effects of cytokine treatment on cognitive behavioral recovery and
neuronal regeneration in soman-poisoned mice. Behav Brain Res. 2011;
221(1):261–70.
54. Miyaki K, Nishiwaki Y, Maekawa K, Ogawa Y, Asukai N, Yoshimura K, Etoh N,
Matsumoto Y, Kikuchi Y, Kumagai N, et al. Effects of sarin on the nervous
system of subway workers seven years after the Tokyo subway sarin attack.
J Occup Health. 2005;47(4):299–304.
55. Nishiwaki Y, Maekawa K, Ogawa Y, Asukai N, Minami M, Omae K, Sarin
Health Effects Study G. Effects of sarin on the nervous system in rescue
team staff members and police officers 3 years after the Tokyo subway sarin
attack. Environ Health Perspect. 2001;109(11):1169–73.
56. Filliat P, Baubichon D, Burckhart MF, Pernot-Marino I, Foquin A, Masqueliez
C, Perrichon C, Carpentier P, Lallement G. Memory impairment after soman
intoxication in rat: correlation with central neuropathology. Improvement
with anticholinergic and antiglutamatergic therapeutics. Neurotoxicology.
1999;20(4):535–49.
57. Filliat P, Coubard S, Pierard C, Liscia P, Beracochea D, Four E, Baubichon D,
Masqueliez C, Lallement G, Collombet JM. Long-term behavioral
consequences of soman poisoning in mice. Neurotoxicology. 2007;28(3):
508–19.
58. Pearson JN, Patel M. The role of oxidative stress in organophosphate and
nerve agent toxicity. Ann N Y Acad Sci. 2016. doi: 10.1111/nyas/13115.
[Epub ahead of print].
59. Gao J, Naughton SX, Wulff H, Singh V, Beck WD, Magrane J, Thomas B,
Kaidery NA, Hernandez CM, Terry Jr AV. Diisopropylfluorophosphate impairs
the transport of membrane-bound organelles in rat cortical axons. J
Pharmacol Exp Ther. 2016;356(3):645–55.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Flannery et al. Journal of Neuroinflammation  (2016) 13:267 Page 16 of 16
